Literature DB >> 3882582

Insulin binding by normal and neoplastic colon tissue.

M Wong, I M Holdaway.   

Abstract

Insulin receptors in human colon tumours, normal colon tissue and mesenteric fat removed at surgery have been identified by measuring the binding of labelled insulin to cell membrane preparations. Insulin binding sites were readily detected in all tissues, with mean +/- SD binding site concentrations of 43 +/- 41, 44 +/- 39, and 44 +/- 35fmol/mg membrane protein, and dissociation constants of 0.73 +/- 0.61, 0.66 +/- 0.41, and 0.78 +/- 0.58nM for microsomal plasma membrane preparations of tumour (n = 23) respectively. The specificity of binding of labelled insulin was similar in tumour and normal colon samples. Binding in normal colon preparations was highest in the epithelium (84fmol/mg membrane protein) and lower in lamina propria (19fmol/mg), submucosa (25fmol/mg) and muscle wall (13fmol/mg). Degradation of labelled insulin was similar in tumour and normal colon preparations. Mean receptor levels were not significantly different between microsomal membrane preparations and plasma membranes partially purified on discontinuous sucrose gradients, quantitated against either unit membrane protein or unit 5'-nucleotidase specific activity. There was a significant negative correlation between insulin levels, but no significant relationship was seen between serum insulin and receptor levels in either colon tumour or tissue preparations from full-thickness normal colon wall. An inverse correlation between serum insulin and receptor levels was, however, apparent in preparations of colonic musosa. These data indicate that although insulin receptors in colon tumours share the same biochemical characteristics as those present in the normal colon, receptors in tumour tissue are less sensitive to down-regulation by ambient insulin than receptors in mesenteric fat cells and normal colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882582     DOI: 10.1002/ijc.2910350309

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  The interaction between glycemic index, glycemic load, and the genetic variant ADIPOQ T45G (rs2241766) in the risk of colorectal cancer: a case-control study in a Korean population.

Authors:  Y-Thanh Lu; Madhawa Gunathilake; Jeonghee Lee; Jae Hwan Oh; Hee Jin Chang; Dae Kyung Sohn; Aesun Shin; Jeongseon Kim
Journal:  Eur J Nutr       Date:  2022-03-03       Impact factor: 4.865

2.  Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study.

Authors:  Rachel Dankner; Michael H Shanik; Lital Keinan-Boker; Cindy Cohen; Angela Chetrit
Journal:  Diabetes Care       Date:  2012-05-22       Impact factor: 19.112

3.  Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistance.

Authors:  Ahmad Aljada; Ayman M Saleh; Salem Al Suwaidan
Journal:  Diagn Pathol       Date:  2014-05-22       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.